IGNITE R61/R33: Preclinical Characterization and In‑Vivo Efficacy for Neurotherapeutics (No Clinical Trials)
NINDS IGNITE R61/R33 grants fund translational preclinical work to characterize therapeutic agents (small molecules, biologics, gene/cell and emerging modalities), perform PK/PD studies in the R61, and demonstrate in‑vivo efficacy in the R33. Awards are phased and milestone-driven: the R61 supports preparatory characterization and PK work and progress to the R33 depends on meeting quantitative…
Source
Award
Dates
Eligibility
Keywords
Supporting Links
Documents
Similar Opportunities
Get the full picture on this opportunity
Create a free Scout account to unlock everything you need to decide fast and win the grant.
-
Instant Fit Analysis
Let our grant expert AI score how well this opportunity aligns with your organization, strengths, gaps, and how to improve your chances of winning funding.
-
Deep agency & funder detail
Program context, sub-agency structure, and a full eligibility breakdown.
-
Source links & full documents
Jump straight to the solicitation and download every attachment.
-
Similar opportunities
Discover related funding matched to your work.
Already have an account? Sign In
Trusted by 500+ Happy Customers